A novel device for cholesteric liquid crystal (CLC)-based microfluidic chips, accommodated in a polydimethylsiloxane material, was invented. In this device, the reorientation of the CLCs was consistently influenced by the surface of the four channel walls and adjacent CLCs. When the inside of the microchannel was coated with the alignment layer, the CLCs oriented homeotropically in a focal conic state under cross-polarizers. Once antigens had bound onto antibodies immobilized onto the orientation sheet-coated channel walls, the light intensity of the CLC molecules converted from a focal conic state to a bright planar state caused by disrupting the CLCs. By means of utilizing pressure-propelling flow, the attachment of antigen/antibody to the CLCs should be detectable within consecutive sequences. The multi-microfluidic CLC-based chips were verified by measuring bovine serum albumin (BSA) and immune complexes of pairs of BSA antigen/antibody. We showed that the multiple microfluidic immunoassaying can be used for measuring BSA and pairs of antigen/ antibody BSA with a detection limit of about 1 ng/mL. The linear range is 0.1 g/mL-1 mg/mL. A limit of immune detection of pairs of BSA antigens/antibodies was 10 ng/mL of BSA plus 1000 ng/mL of the anti-BSA antibodies was observed. According to this innovative creation of immunoassaying, an unsophisticated multi-detection device with CLC-based labeling-free microfluidic chips is presented.

Original languageEnglish
Article number1463
Issue number9
Publication statusPublished - 2021


  • BSA
  • Cholesteric liquid crystal
  • Microfluidic chip

ASJC Scopus subject areas

  • Chemistry(all)
  • Polymers and Plastics


Dive into the research topics of 'Sensitive, color-indicating and labeling-free multi-detection cholesteric liquid crystal biosensing chips for detecting albumin'. Together they form a unique fingerprint.

Cite this